Covid vaccine Sputnik V likely to provide up to 2 years of immunity

Russian coronavirus vaccine Sputnik V is likely to provide up to 2 years of immunity against Covid-19, as compared to 4-5 months of immunity that might be achieved by using Covid vaccine developed by Pfizer and BioNTech. The Gamaleya research centre, which is developing Sputnik V vaccine, made this claim on Monday.

A press release by researchers at the Gamaleya Institute announced that Russia's experimental coronavirus vaccine Sputnik-V shows the efficacy of 91.4 per cent based on data analysis of the final control point of clinical trials. Watch this video to know more